a-syn POSTMORTEM, a-syn SH-SY5Y + Cullen, a-syn PC only, FRACTIONATION
Choi 2011 요약
의미: 1. Monomeric a-syn doesn’t change in PD or GD or PD+GD or PD with GBA hetero
| source | fraction | readout | normal | synopathy only | (GBA mutation homo or hetero) + synopathy | GBA mutation homo only |
|---|---|---|---|---|---|---|
| Choi (cerebral cx homogenates) 2011 | TBS soluble (soluble, cytosolic) | monomer | Normal과 같음. | Normal과 같음. | ||
| Oligomer | 약간 | Normal과 같음 | Normal과 같음. | Normal과 같음. | ||
| SDS soluble (soluble, memb bound) | Monomer | normal보다 증가 | normal보다 증가 | normal보다 증가 | ||
| oligomer | absent | present | Present | absent (의미: neither GBA deficiency nor mutation alone result in a-syn aggregation) | ||
| Urea Soluble (insoluble) | Monomer | Normal과 비슷함 | Normal과 비슷함 | |||
| oligomer | 없음 | normal보다 증가 | normal보다 증가 | 없음 (의미: neither GBA deficiency nor mutation alone result in a-syn aggregation) |
Postmortem rows (Mazzulli 2011, Murphy 2013, Murphy 2014)
| source | fraction | readout | normal | synopathy only | (GBA mutation homo or hetero) + synopathy | GBA mutation homo only |
|---|---|---|---|---|---|---|
| Mazzulli (bidirectional) 2011 Postmortem | TBS soluble (soluble, cytosolic) | monomer | 이 군은 없었음. | Homoz: nl보다 ↑ Hetero: nl과 같음 | Normal과 별 차이 없는 듯 보임. | |
| Oligomer | 이 군은 없었음. | Homoz: nl보다 ↑ Hetero: nl보다 쬐끔(?) ↑ | Normal과 차이없음. (absence of oligomer 라고 본문에서 시인했음.) | |||
| Murphy 2013 Postmortem | TBS soluble | monomer | TBS soluble data not shown, but only mentione that SDS soluble fraction increased compared to TBS soluble, indicating A-syn become insoluble (the shift from soluble to more insoluble) 그러나, SDS soluble도 여전히 soluble 하므로, solubility 차이보다는 localisation차이로 설명하는 게 낫지 않나? | Not applicable | ||
| Oligomer | Not shown | Not applicable | ||||
| SDS soluble | Monomer | ↑ than normal | Not shown | |||
| oligomer | Not shown | |||||
| Murphy 2014 Postmortem | TBS soluble | monomer | No change (synopathy only, ant cingulate cx & parahippocampal cx) | Not applicable | ||
| Oligomer | Not shown | Not applicable | ||||
| SDS soluble | Monomer | ↑ than normal (synopathy only, ant cingulate cx) | Not applicable | |||
| oligomer | Not shown | Not applicable | ||||
Zhou : Postmortem, PD brain에서 insolubility 증가함. (SDS soluble 과 urea soluble 다 같이 얘기하는 것 같음)
a-syn SH-SY5Y + Cullen: probably this is all for cell line]
| row / model | Cleeter | Manning-Bog (2009) | Dermentzaki (2013) | Cullen |
|---|---|---|---|---|
| duration | 30 days | 2 days | 7 days (unfractioned) 7 days | |
| concentration | 50uM | 50-200 | 50,100,200uM 200uM | 10,50,100uM (<1h or 24h) |
| SH-SY5Y indiff / monomer | ↑ (unfractioned) | No change (unfractioned) | -No change (unfractioned, collection시 TX썼으니 membrane-bound도 모았을것임) Not done |
Soluble fraction (ie cytosolic + memb) 이건 PC12에서만 CBE 썼고, ELISA로 total concentration 봤음. (ie both monomer & oligomer) |
| SH-SY5Y indiff / oligomer | Not done | NA | 안 보여줌 | Results: mutant forms increased SNCA levels (not all인데?) but the wild-type (ie CBE) had variable effects |
| SH-SY5Y diff / monomer | Not done | ↑ (unfractioned) | No change (unfractioned, collection시 TX썼으니 membrane-bound도 모았을것임) No change (both cytosolic & memb bound) | GBA activity 낮은 경우들은 WT+CBE 밖에 없네. 여기쓰인 GBA mutant 들은 다 GBA Activity가 안 낮으니, overall 참고자료에서 빼는 게 안 낫나? |
| SH-SY5Y diff / oligomer | Not done | NA | 안 보여줌 No change (both cytosolic & memb bound) |
a-syn PC only
| source / row | note |
|---|---|
| Mazzulli (2011) | CBE NOT USED (ie mouse primary cortical neuronal cultures, in which GBA had been partly depleted via RNAi, (보통 KD라고 하네?) and human iPS neurons derived from a GBA mutation carrier) |
| same / 1. | mouse primary cortical neuronal cultures, in which GBA had been partly depleted via RNAi (resulting in 50% ↓ GBA expression): |
| same / 1.a | ↑ (1.8 fold) monomer a-syn (fraction not specified), (oligomer not shown), |
| same / 1.b | Tx-soluble (fig 3D): ↑ monomer, ↑ oligomer (by native SEC/WB) |
| same / 1.c | Tx-Insoluble (fig 3E): ↑ oligomer, (monomer은 별차이 안 느껴짐) |
| same / 2. | iPS cells derived from skin fibroblasts of a GD patient (containing <10% dopaminergic cells (fig 2E): ↑ (dramatic increase) monomer a-syn (TX-soluble, unfractioned), (oligomer not shown) |
| GBA activity assay | not required |
| Dermentzaki (2013) | Rat cortical neuron cultures (E18) |
| same | 아래 넷 모두 control과 no difference : 모두 monomer, soluble, unfractioned lysates (collection시 TX썼으니 membrane-bound도 모았을것임) |
| same | -100uM 7d / -100uM 10d / -200uM 7d / -200uM 10d |
| Osellame | 알고 봤더니 in vivo (midbrain) |
FRACTIONATION
| fraction / row | protocol | notes |
|---|---|---|
| won normal | 50mM Tris-HCl, 1% SDS / Boil / Spin: 13,000g for 10 min / supernatant | boil하고 oligomer없겠구만. / 약짧spin이니 / 이건 unfractionated sample 이라 할 수 있겠는데, (ultracentrifugation 안 했으나) 1% SDS 썼으니 protein 이, membrane에서 remove 되어 녹아 있는 상태이니, cytosolic과 membrane form 이 같이있겠구만. |
| TBS-soluble | TBS buffer / Spin: 1,000g for 4 min→Sup / Spin: 100,000g for 1h→sup | Murphy2013: the same and labelled TBS-soluble as well. / Murphy2013: this contains cytosolic proteins or soluble / Spin: 1,000g for 4 min 통해 unbroken cell등 제거, Spin: 100,000g for 1h to sediment membrane-bound organelles / 내거: 여기서 monomer도 나왔음. |
| SDS-soluble | 위 pellet → TBS, 5% SDS, 1% Triton X-100 → Spin: 100,000g for 30min→sup | 1. Murphy2013: similar except no T-X100 and labelled SDS-soluble as well. / 2. Dermentzaki: similar except no SDS and labelled TritonX-soluble as well / Murphy2013: this contains membrane-associated proteins |
| SDS note | (WIKI: SDS) can be used to keep membrane proteins in solution during purification; however, because SDS causes denaturation, milder detergents such as Triton X-100 or CHAPS can be used to retain the protein's native conformation during complete purification. | |
| 한 것 / urea-soluble | 위 pellet → 1X TBS w/ 8% SDS & 8M urea (by sonication) | Murphy2013: 'detergent insoluble urea-soluble fraction' / Choi: the same and "urea soluble" / Murphy2013: this contains resolubilized protein aggregates or 'insoluble' proteins. / Urea strongly denatures proteins. |
Bottom continuation
| source | visible cells |
|---|---|
| Gegg 2015 | in areas of the brain with low asyn pathology 라고 언급있을 뿐 그 level은 언급 없음. |
| Gegg 2012 | ↓ gba activity & expression(?) in PD; adjacent cell: a-syn or mitochondrial dysfunction → ↓ GBA activity |
| Parkkinen 2011 | PD+heterozygous GBA mutation VS PD only; adjacent cell: No difference in the number of LB aggregates; note: Normal 과 비교한 게 아니니까 당연한 결과 아닌가? |
| Murphy |
<table Below by Sidransky 2012 review>
| Author | Model | Result | Criticism |
|---|---|---|---|
| (2013) | (undifferentiated) 1. SH-SY5Y + CBE | 1. ↓ Mito functio |
Uncertain Spans
| location | transcription | uncertainty |
|---|---|---|
| Choi 2011 / SDS soluble oligomer | absent / present / Present / absent placements | The cells are small with red absent/Present text; row/column placement was inferred from visual alignment. |
| FRACTIONATION / leftmost labels | won normal, 한 것, 위 pellet | The leftmost labels are clipped at the photo edge; partial Korean labels are preserved as visible. |
| FRACTIONATION / urea row | 8% SDS & 8M urea | The original transcription showed & & (doubled &); the duplicate was likely an OCR artifact and is reduced to a single &. |
| Bottom continuation | (2013) row in the Sidransky table fragment | The first visible Sidransky row’s author column is reduced to a year (2013); the full author/title is in 20240722_182146. |